These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 30131425)

  • 1. The Effect of Increasing Dialysate Magnesium on Serum Calcification Propensity in Subjects with End Stage Kidney Disease: A Randomized, Controlled Clinical Trial.
    Bressendorff I; Hansen D; Schou M; Pasch A; Brandi L
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1373-1380. PubMed ID: 30131425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Calcification Propensity and Clinical Events in CKD.
    Bundy JD; Cai X; Mehta RC; Scialla JJ; de Boer IH; Hsu CY; Go AS; Dobre MA; Chen J; Rao PS; Leonard MB; Lash JP; Block GA; Townsend RR; Feldman HI; Smith ER; Pasch A; Isakova T;
    Clin J Am Soc Nephrol; 2019 Nov; 14(11):1562-1571. PubMed ID: 31658949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood Calcification Propensity, Cardiovascular Events, and Survival in Patients Receiving Hemodialysis in the EVOLVE Trial.
    Pasch A; Block GA; Bachtler M; Smith ER; Jahnen-Dechent W; Arampatzis S; Chertow GM; Parfrey P; Ma X; Floege J
    Clin J Am Soc Nephrol; 2017 Feb; 12(2):315-322. PubMed ID: 27940458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Calcification Propensity Represents a Good Biomarker of Vascular Calcification: A Systematic Review.
    Pluquet M; Kamel S; Choukroun G; Liabeuf S; Laville SM
    Toxins (Basel); 2022 Sep; 14(9):. PubMed ID: 36136575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of increasing dialysate magnesium on calciprotein particles, inflammation and bone markers: post hoc analysis from a randomized controlled clinical trial.
    Bressendorff I; Hansen D; Pasch A; Holt SG; Schou M; Brandi L; Smith ER
    Nephrol Dial Transplant; 2021 Mar; 36(4):713-721. PubMed ID: 31764984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Flux Hemodialysis and High-Volume Hemodiafiltration Improve Serum Calcification Propensity.
    Dekker M; Pasch A; van der Sande F; Konings C; Bachtler M; Dionisi M; Meier M; Kooman J; Canaud B
    PLoS One; 2016; 11(4):e0151508. PubMed ID: 27064679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.
    Chen W; Fitzpatrick J; Monroy-Trujillo JM; Sozio SM; Jaar BG; Estrella MM; Serrano J; Anokhina V; Miller BL; Melamed ML; Bushinsky DA; Parekh RS
    Am J Kidney Dis; 2021 Mar; 77(3):346-354. PubMed ID: 32800846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrate-Buffered, Magnesium-Enriched Dialysate on Calcification Propensity in Hemodialysis Patients - The CitMag Study.
    Cejka D; Thiem U; Blinzler E; Machacek J; Voelkl J; Smith ER; Pasch A; Haller MC
    Kidney Int Rep; 2024 Jun; 9(6):1765-1773. PubMed ID: 38899177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum calcification propensity predicts all-cause mortality in predialysis CKD.
    Smith ER; Ford ML; Tomlinson LA; Bodenham E; McMahon LP; Farese S; Rajkumar C; Holt SG; Pasch A
    J Am Soc Nephrol; 2014 Feb; 25(2):339-48. PubMed ID: 24179171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Citric-acid dialysate improves the calcification propensity of hemodialysis patients: A multicenter prospective randomized cross-over trial.
    Ter Meulen KJ; Dekker MJE; Pasch A; Broers NJH; van der Sande FM; van der Net JB; Konings CJAM; Gsponer IM; Bachtler MDN; Gauly A; Canaud B; Kooman JP
    PLoS One; 2019; 14(12):e0225824. PubMed ID: 31805104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Effects of Etelcalcetide and Maxacalcitol on Serum Calcification Propensity in Secondary Hyperparathyroidism: A Randomized Clinical Trial.
    Shoji T; Nakatani S; Kabata D; Mori K; Shintani A; Yoshida H; Takahashi K; Ota K; Fujii H; Ueda S; Nishi S; Nakatani T; Yoshiyama M; Goto K; Hamada T; Imanishi M; Ishimura E; Kagitani S; Kato Y; Kumeda Y; Maekawa K; Matsumura T; Nagayama H; Obi Y; Ohno Y; Sai Y; Sakurai M; Sasaki S; Shidara K; Shoji S; Tsujimoto Y; Yamakawa K; Yasuda H; Yodoi S; Inaba M; Emoto M
    Clin J Am Soc Nephrol; 2021 Apr; 16(4):599-612. PubMed ID: 33685864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dialysis initiation improves calcification propensity.
    Ponte B; Pruijm M; Pasch A; Dufey-Teso A; Martin PY; de Seigneux S
    Nephrol Dial Transplant; 2020 Mar; 35(3):495-502. PubMed ID: 31738424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Calcification Propensity and the Risk of Cardiovascular and All-Cause Mortality in the General Population: The PREVEND Study.
    Eelderink C; Te Velde-Keyzer CA; Frenay AS; Vermeulen EA; Bachtler M; Aghagolzadeh P; van Dijk PR; Gansevoort RT; Vervloet MG; Hillebrands JL; Bakker SJL; van Goor H; Pasch A; de Borst MH;
    Arterioscler Thromb Vasc Biol; 2020 Aug; 40(8):1942-1951. PubMed ID: 32493170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcification Propensity and Survival among Renal Transplant Recipients.
    Keyzer CA; de Borst MH; van den Berg E; Jahnen-Dechent W; Arampatzis S; Farese S; Bergmann IP; Floege J; Navis G; Bakker SJ; van Goor H; Eisenberger U; Pasch A
    J Am Soc Nephrol; 2016 Jan; 27(1):239-48. PubMed ID: 25925688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Calcification Propensity Is a Strong and Independent Determinant of Cardiac and All-Cause Mortality in Kidney Transplant Recipients.
    Dahle DO; Åsberg A; Hartmann A; Holdaas H; Bachtler M; Jenssen TG; Dionisi M; Pasch A
    Am J Transplant; 2016 Jan; 16(1):204-12. PubMed ID: 26375609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity-A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial.
    Bressendorff I; Hansen D; Schou M; Silver B; Pasch A; Bouchelouche P; Pedersen L; Rasmussen LM; Brandi L
    Kidney Int Rep; 2017 May; 2(3):380-389. PubMed ID: 29142966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetate-free, citrate-acidified bicarbonate dialysis improves serum calcification propensity-a preliminary study.
    Lorenz G; Mayer CC; Bachmann Q; Stryeck S; Braunisch MC; Haller B; Carbajo-Lozoya J; Schmidt A; Witthauer S; Abuzahu J; Kemmner S; Angermann S; Koneru N; Wassertheurer S; Bieber R; Heemann U; Madl T; Pasch A; Schmaderer C
    Nephrol Dial Transplant; 2018 Nov; 33(11):2043-2051. PubMed ID: 29860419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of Supraphysiological Dialysate Magnesium on Arterial Stiffness, Hemodynamic Profile, and Endothelial Function in Hemodialysis: A Randomized Crossover Study Followed by a Non-Controlled Follow-Up Phase.
    Del Giorno R; Lavorato Hadjeres S; Stefanelli K; Allegra G; Zapparoli C; Predrag L; Berwert L; Gabutti L
    Adv Ther; 2020 Dec; 37(12):4848-4865. PubMed ID: 32996010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcification Propensity of Serum is Independent of Excretory Renal Function.
    Bielesz B; Reiter T; Marculescu R; Gleiss A; Bojic M; Kieweg H; Cejka D
    Sci Rep; 2017 Dec; 7(1):17941. PubMed ID: 29263429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.